| 标题 |
Ivonescimab plus chemotherapy versus placebo plus chemotherapy in patients with advanced EGFR-mutated non-small-cell lung cancer after disease progression on EGFR tyrosine kinase inhibitor therapy (HARMONi): a multicentre, randomised, double-blind, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Oncology 作者:Xiuning Le; Antonio Passaro; Yuanyuan Zhao; Yan Huang; Janessa Laskin; et al 出版日期:2026-08-25 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)